Pneumonia Testing Market By Types, By Method, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030

Description

List of Tables

Pneumonia is indicated as a complex infection, which affects the lower part of the respiratory tract along with the deposition of cough in the lungs. It may even occur as a consequence of an upper tract infection. Frequently, it occurs in people with weakened immunity, the geriatric population, and children. Biotechnological methods can be used for testing of pneumonia, such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).

The major driving factors contributing to the growth of the pneumonia market are an increase in awareness regarding early diagnosis, a rise in the popularity of point of care (POC)testing, and surge in government expenditures on healthcare. However, limited detection capability, the accuracy of some of the pneumonia testing products, and regulatory & economic hurdles hamper the market growth. Some of the factors, such as an increase in the adoption of molecular diagnostic testing and untapped markets in developing countries are expected to provide lucrative growth opportunities for the pneumonia testing market.

The pneumonia testing market is segmented on the basis of, and region. Method, technology, type & end user. In terms of method, the market is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on the end-user, it is categorized into hospitals, diagnostic laboratories, home care, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the market include Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pneumonia testing market analysis from 2020 to 2030 to identify the prevailing pneumonia testing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pneumonia testing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pneumonia testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Types

Consumables
Analyzers

By Method

Molecular Diagnostics
Point of Care Testing
Immunodiagnostics

By Technology

Enzyme Linked Immunosorbant Assay
Immunofluoroscence
Western Blot
Polymerase Chain Reaction
Imunohistochemistry
Others

By End User

Hospitals
Diagnostic Laboratories
Homecare
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abott Laboratories
- F.hoffman La roche
- Thermofischer Inc
- Hologic Inc
- Biomerieux SA
- Quidel Corporation
- Bio Rad laborateries
- Beckton and Dickinson Company
- AdvanDx
- Beckman Coulter

Product Code: A03434

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PNEUMONIA TESTING MARKET, BY TYPES

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Consumables
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Analyzers
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country

CHAPTER 5: PNEUMONIA TESTING MARKET, BY METHOD

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Immunodiagnostics
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Molecular Diagnostics
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Point of Care Testing
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: PNEUMONIA TESTING MARKET, BY TECHNOLOGY

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Enzyme Linked Immunosorbent Assay
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Immunofluorescence
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Western Blot
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Polymerase Chain Reaction
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
6.6 Immunohistochemistry
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country
6.7 Others
- 6.7.1 Key market trends, growth factors and opportunities
- 6.7.2 Market size and forecast, by region
- 6.7.3 Market analysis by country

CHAPTER 7: PNEUMONIA TESTING MARKET, BY END USER

7.1 Overview
- 7.1.1 Market size and forecast
7.2 Hospitals
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
7.3 Diagnostic Laboratories
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
7.4 Homecare
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
7.5 Others
- 7.5.1 Key market trends, growth factors and opportunities
- 7.5.2 Market size and forecast, by region
- 7.5.3 Market analysis by country

CHAPTER 8: PNEUMONIA TESTING MARKET, BY REGION

8.1 Overview
- 8.1.1 Market size and forecast
8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Types
- 8.2.3 North America Market size and forecast, by Method
- 8.2.4 North America Market size and forecast, by Technology
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
  - 8.2.6.1 U.S.
  - 8.2.6.1.1 Market size and forecast, by Types
  - 8.2.6.1.2 Market size and forecast, by Method
  - 8.2.6.1.3 Market size and forecast, by Technology
  - 8.2.6.1.4 Market size and forecast, by End User
  - 8.2.6.2 Canada
  - 8.2.6.2.1 Market size and forecast, by Types
  - 8.2.6.2.2 Market size and forecast, by Method
  - 8.2.6.2.3 Market size and forecast, by Technology
  - 8.2.6.2.4 Market size and forecast, by End User
  - 8.2.6.3 Mexico
  - 8.2.6.3.1 Market size and forecast, by Types
  - 8.2.6.3.2 Market size and forecast, by Method
  - 8.2.6.3.3 Market size and forecast, by Technology
  - 8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Types
- 8.3.3 Europe Market size and forecast, by Method
- 8.3.4 Europe Market size and forecast, by Technology
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
  - 8.3.6.1 Germany
  - 8.3.6.1.1 Market size and forecast, by Types
  - 8.3.6.1.2 Market size and forecast, by Method
  - 8.3.6.1.3 Market size and forecast, by Technology
  - 8.3.6.1.4 Market size and forecast, by End User
  - 8.3.6.2 France
  - 8.3.6.2.1 Market size and forecast, by Types
  - 8.3.6.2.2 Market size and forecast, by Method
  - 8.3.6.2.3 Market size and forecast, by Technology
  - 8.3.6.2.4 Market size and forecast, by End User
  - 8.3.6.3 U.K.
  - 8.3.6.3.1 Market size and forecast, by Types
  - 8.3.6.3.2 Market size and forecast, by Method
  - 8.3.6.3.3 Market size and forecast, by Technology
  - 8.3.6.3.4 Market size and forecast, by End User
  - 8.3.6.4 Italy
  - 8.3.6.4.1 Market size and forecast, by Types
  - 8.3.6.4.2 Market size and forecast, by Method
  - 8.3.6.4.3 Market size and forecast, by Technology
  - 8.3.6.4.4 Market size and forecast, by End User
  - 8.3.6.5 Spain
  - 8.3.6.5.1 Market size and forecast, by Types
  - 8.3.6.5.2 Market size and forecast, by Method
  - 8.3.6.5.3 Market size and forecast, by Technology
  - 8.3.6.5.4 Market size and forecast, by End User
  - 8.3.6.6 Rest of Europe
  - 8.3.6.6.1 Market size and forecast, by Types
  - 8.3.6.6.2 Market size and forecast, by Method
  - 8.3.6.6.3 Market size and forecast, by Technology
  - 8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Types
- 8.4.3 Asia-Pacific Market size and forecast, by Method
- 8.4.4 Asia-Pacific Market size and forecast, by Technology
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
  - 8.4.6.1 Japan
  - 8.4.6.1.1 Market size and forecast, by Types
  - 8.4.6.1.2 Market size and forecast, by Method
  - 8.4.6.1.3 Market size and forecast, by Technology
  - 8.4.6.1.4 Market size and forecast, by End User
  - 8.4.6.2 China
  - 8.4.6.2.1 Market size and forecast, by Types
  - 8.4.6.2.2 Market size and forecast, by Method
  - 8.4.6.2.3 Market size and forecast, by Technology
  - 8.4.6.2.4 Market size and forecast, by End User
  - 8.4.6.3 Australia
  - 8.4.6.3.1 Market size and forecast, by Types
  - 8.4.6.3.2 Market size and forecast, by Method
  - 8.4.6.3.3 Market size and forecast, by Technology
  - 8.4.6.3.4 Market size and forecast, by End User
  - 8.4.6.4 India
  - 8.4.6.4.1 Market size and forecast, by Types
  - 8.4.6.4.2 Market size and forecast, by Method
  - 8.4.6.4.3 Market size and forecast, by Technology
  - 8.4.6.4.4 Market size and forecast, by End User
  - 8.4.6.5 South Korea
  - 8.4.6.5.1 Market size and forecast, by Types
  - 8.4.6.5.2 Market size and forecast, by Method
  - 8.4.6.5.3 Market size and forecast, by Technology
  - 8.4.6.5.4 Market size and forecast, by End User
  - 8.4.6.6 Rest Of Asia Pacific
  - 8.4.6.6.1 Market size and forecast, by Types
  - 8.4.6.6.2 Market size and forecast, by Method
  - 8.4.6.6.3 Market size and forecast, by Technology
  - 8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Types
- 8.5.3 LAMEA Market size and forecast, by Method
- 8.5.4 LAMEA Market size and forecast, by Technology
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
  - 8.5.6.1 Brazil
  - 8.5.6.1.1 Market size and forecast, by Types
  - 8.5.6.1.2 Market size and forecast, by Method
  - 8.5.6.1.3 Market size and forecast, by Technology
  - 8.5.6.1.4 Market size and forecast, by End User
  - 8.5.6.2 Saudi Arabia
  - 8.5.6.2.1 Market size and forecast, by Types
  - 8.5.6.2.2 Market size and forecast, by Method
  - 8.5.6.2.3 Market size and forecast, by Technology
  - 8.5.6.2.4 Market size and forecast, by End User
  - 8.5.6.3 South Africa
  - 8.5.6.3.1 Market size and forecast, by Types
  - 8.5.6.3.2 Market size and forecast, by Method
  - 8.5.6.3.3 Market size and forecast, by Technology
  - 8.5.6.3.4 Market size and forecast, by End User
  - 8.5.6.4 Rest of LAMEA
  - 8.5.6.4.1 Market size and forecast, by Types
  - 8.5.6.4.2 Market size and forecast, by Method
  - 8.5.6.4.3 Market size and forecast, by Technology
  - 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 Abott Laboratories
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
10.2 F.hoffman La roche
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
10.3 Thermofischer Inc
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
10.4 Hologic Inc
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
10.5 Biomerieux SA
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
10.6 Quidel Corporation
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
10.7 Bio Rad laborateries
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
10.8 Beckton and Dickinson Company
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
10.9 AdvanDx
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
10.10 Beckman Coulter
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments